Join
Live feed
·
INSIDERFilingvia Quantisnow
Celldex Therapeutics Inc. logo

SVP & GENERAL COUNSEL Jimenez Freddy A. sold $121,210 worth of shares (4,166 units at $29.09), decreasing direct ownership by 12% to 30,796 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CLDX· Celldex Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLDX (Celldex Therapeutics Inc.) and more on Quantisnow.